{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:07:17Z","timestamp":1794330437182,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","award":["N CP2_10\/2018"],"award-info":[{"award-number":["N CP2_10\/2018"]}],"id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["08045818"],"award-info":[{"award-number":["08045818"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["08045823"],"award-info":[{"award-number":["08045823"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022720","name":"Fondazione Regionale per la Ricerca Biomedica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtct.2023.12.671","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:59:36Z","timestamp":1704200376000},"page":"433.e1-433.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-0446","authenticated-orcid":false,"given":"Francesco","family":"Saglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-3785","authenticated-orcid":false,"given":"Daria","family":"Pagliara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9145-3691","authenticated-orcid":false,"given":"Francesco Paolo","family":"Tambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Calore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-3654","authenticated-orcid":false,"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-900X","authenticated-orcid":false,"given":"Franca","family":"Fagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.12.671_bib0001","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","article-title":"Current use and trends in hematopoietic cell transplantation in the United States","volume":"23","author":"D'Souza","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbmt.2014.09.006","article-title":"Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy","volume":"21","author":"Eapen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0003","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bjh.18610","article-title":"Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany","volume":"201","author":"Frietsch","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.12.671_bib0004","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/bloodadvances.2017010280","article-title":"Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study","volume":"1","author":"Eissa","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.671_bib0005","doi-asserted-by":"crossref","first-page":"e29846","DOI":"10.1002\/pbc.29846","article-title":"Pain, depressive symptoms, and health-related quality of life among survivors of pediatric hematopoietic stem cell transplant","volume":"69","author":"Klages","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.12.671_bib0006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pcl.2009.11.008","article-title":"The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children","volume":"57","author":"Baker","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jtct.2023.12.671_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11912-018-0719-5","article-title":"Long-term effects of myeloablative allogeneic hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia","volume":"20","author":"Lawitschka","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jtct.2023.12.671_bib0008","doi-asserted-by":"crossref","first-page":"99.e1","DOI":"10.1016\/j.jtct.2021.09.018","article-title":"Impact of treosulfan exposure on early and long-term clinical outcomes in pediatric allogeneic hematopoietic stem cell transplantation recipients: a prospective multicenter study","volume":"28","author":"van der Stoep","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.671_bib0009","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ejh.13828","article-title":"A retrospective study of treosulfan versus busulfan-based conditioning in pediatric patients","volume":"109","author":"Olivas-Maz\u00f3n","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.12.671_bib0010","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.bbmt.2019.05.005","article-title":"Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0011","doi-asserted-by":"crossref","first-page":"529.e1","DOI":"10.1016\/j.jtct.2023.05.003","article-title":"Effect of busulfan and treosulfan on gonadal function after allogeneic stem cell transplantation in children and adolescents with nonmalignant diseases is not exposure-dependent","volume":"29","author":"van der Stoep","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.671_bib0012","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children's Oncology Group report","volume":"22","author":"Chow","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0014","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1704481","article-title":"Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood","volume":"33","author":"Bakker","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0016","doi-asserted-by":"crossref","unstructured":"Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-3052.","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045"},{"key":"10.1016\/j.jtct.2023.12.671_bib0017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-13-0694","article-title":"Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence","volume":"170","author":"Vatanen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jtct.2023.12.671_bib0018","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bmt.1702384","article-title":"Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan\/cyclophosphamide","volume":"25","author":"Afify","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1064146","article-title":"Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: state of the art and practical recommendations for a risk-based follow-up","volume":"13","author":"Cattoni","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jtct.2023.12.671_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1034\/j.1600-0420.2002.800217.x","article-title":"Cataract in children after bone marrow transplantation: relation to conditioning regimen","volume":"80","author":"Holmstr\u00f6m","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jtct.2023.12.671_bib0021","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pcl.2020.07.007","article-title":"Cardiovascular and pulmonary challenges after treatment of childhood cancer","volume":"67","author":"Visscher","year":"2020","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jtct.2023.12.671_bib0022","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41375-022-01693-z","article-title":"Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL\u2014long-term follow-up from the prospective ALL-SCT 2003 trial","volume":"36","author":"Eichinger","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.12.671_bib0023","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.671_bib0024","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"Majhail","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.671_bib0025","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/s41409-020-0869-6","article-title":"Treosulfan\u2013fludarabine\u2013thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies","volume":"55","author":"Kalwak","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0026","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","article-title":"Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience","volume":"24","author":"Slatter","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.671_bib0027","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.jtct.2022.05.036","article-title":"Male gonadal function after pediatric hematopoietic stem cell transplantation: a systematic review","volume":"28","author":"Mathiesen","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.671_bib0028","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/pbc.25162","article-title":"Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood","volume":"61","author":"Bresters","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.12.671_bib0029","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/EJE-21-0351","article-title":"Serum anti-M\u00fcllerian hormone as a marker of ovarian reserve after cancer treatment and\/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment","volume":"185","author":"Molinari","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jtct.2023.12.671_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723024107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723024107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:01:50Z","timestamp":1762639310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723024107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666636723024107"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.671","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}